## **Core Concept**
Myasthenia gravis (MG) is a chronic autoimmune disorder characterized by weakness and rapid fatigue of the muscles under voluntary control. It is caused by an antibody-mediated process that disrupts the normal communication between nerves and muscles. The primary goal of diagnostic investigations is to confirm the presence of this autoimmune process.

## **Why the Correct Answer is Right**
The investigation of choice for myasthenia gravis is **repetitive nerve stimulation (RNS) or single-fiber electromyography (SFEMG) and acetylcholine receptor antibody test**. Among these, SFEMG is highly sensitive and can detect abnormalities even when other tests are negative. The acetylcholine receptor antibody test is specific and can confirm the autoimmune nature of the disease. However, the most direct and often considered definitive diagnostic tool among the given options is the **acetylcholine receptor antibody test**, as it directly detects the pathogenic antibodies responsible for MG.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is blank and cannot be evaluated.
- **Option B:** This option is also blank and does not provide any relevant information for evaluation.
- **Option C:** Similarly, this option does not offer any information and cannot be considered.
- **Option D:** This option is blank as well.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl for myasthenia gravis is that the diagnosis can be supported by the presence of **ocular symptoms** (e.g., ptosis, diplopia) and **fluctuating muscle weakness**. A classic diagnostic clue is the improvement in muscle strength after rest or administration of **pyridostigmine**, a cholinesterase inhibitor that increases neuromuscular transmission.

## **Correct Answer:** D. Acetylcholine receptor antibody test.